ARMP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Armata Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.45 USD 12.75% Market Closed

Market Cap: $126.6m

A	Armata Pharmaceuticals Inc AMEX:ARMP	US
	Lamor Corporation Oyj F:GB9	FI
	Ritchie Bros Auctioneers Inc TSX:RBA	CA

Profitability Summary

Armata Pharmaceuticals Inc's profitability score is 22/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-734%

Negative 3Y Average Operating Margin

-786%

Operating Margin is Increasing

-1 026% > -734%

Negative Net Margin

-3 467%

Negative 3Y Average Net Margin

-1 809%

Declining Net Margin

-1 466% > -3 467%

Negative Free Cash Flow Margin

-465%

Negative 3Y Average Free Cash Flow Margin

-750%

Free Cash Flow Margin is Increasing

-1 357% > -465%

Exceptional ROE

128%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-51%

Declining ROIC

-56% > -58%

View All

Hide

Collapse

22 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.